Craft

Decibel Therapeutics

Decibel Therapeutics Summary

Company Summary

Overview
Decibel Therapeutics is a biotechnology company that discovers and develops transformative treatments to restore and improve hearing and balance. It designs a platform that integrates single-cell genomics and bioinformatic analyses, precision gene therapy technologies, and expertise in inner ear biology The company develops treatments for congenital, monogenic hearing loss and helps patients to regenerate inner ear hair cells.
Type
Subsidiary
Status
Active
Founded
2015
HQ
Boston, MA, US | view all locations
Website
http://decibeltx.com/
Cybersecurity rating
Sectors

Key People

  • Bridget Cleff

    Bridget Cleff, Vice President, New Product Planning

  • Elaine Cope

    Elaine Cope, Vice President, Operations

    • Elaine Kernbauer

      Elaine Kernbauer, Vice President, Development Operations

      • Courtney Shanks

        Courtney Shanks, Vice President, Program Management, Strategy and Operations

        Operating MetricsView all

        Trademark Applications (US)

        32

        FY, 2020

        Provisional Patent Applications (US)

        10

        FY, 2020

        Patents (US)

        3

        FY, 2020

        LocationsView all

        1 location detected

        • Boston, MA HQ

          United States

          1325 Boylston St #500

        Decibel Therapeutics Financials

        Summary Financials

        Net income (Q2, 2023)
        ($18.1M)
        Cash (Q2, 2023)
        $39.8M
        EBIT (Q2, 2023)
        ($19.0M)

        Footer menu